通过伊米基莫德使瘤血管系统正常化:为TLR7激动剂提出了一种新的抗癌治疗指示

Jarosz-Biej Magdalena1, Czapla Justyna2, Ciepła Joanna2

  • 1Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland. Magdalena.Jarosz-Biej@gliwice.nio.gov.pl.

概括

伊米基莫德 (IMQ) 是一种托尔类受体7激动剂,在50μg剂量时有效地使瘤血管正常化,减少缺氧并增强抗癌疗法. 较高的剂量被证明是有害的,突出了最佳剂量的协同效应.